Drug name - Eskata
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10098910 | ACLARIS | Peroxide formulations and methods and applicators for using the same |
Apr, 2035
(12 years from now) | |
| US9980983 | ACLARIS | Peroxide formulations and methods and applicators for using the same |
Apr, 2035
(12 years from now) | |
| US10493103 | ACLARIS | Peroxide formulations and methods and applicators for using the same |
Apr, 2035
(12 years from now) | |
| US10729720 | ACLARIS | Peroxide formulations and methods and applicators for using the same |
Apr, 2035
(12 years from now) | |
| US9675639 | ACLARIS | Peroxide formulations and methods and applicators for using the same |
Jul, 2035
(12 years from now) | |
Drugs and Companies using HYDROGEN PEROXIDE ingredient
Treatment: Treatment of seborrheic keratoses that are raised
Dosage: SOLUTION;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 40% | SOLUTION;TOPICAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.